Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Generic User Fee Hikes Could Disrupt US FDA Drug Pricing Campaign

Aug 28 2017

• By Derrick Gingery

US-Money-and-Pills_V2_1200x675

Related Content

GDUFA: Fee Avoidance Affects Rates Again

Aug 12 2013

GDUFA Facility Fees Will Be Significantly Higher Than Expected

Jan 16 2013

Generic User Fees Need Small Business Waiver, Firms Say; Congress May Agree

Jun 24 2013

Generic Drug Puzzle: Why Did ANDA Submissions Spike Again?

Apr 11 2017

FDA's Generic Approvals Catch A Bit Of Breath In July But Continue At Fast Pace

Aug 07 2017

Gottlieb Places Drug Pricing Out Front In First Speech To US FDA Staff

May 16 2017

Generic Drug User Fees Will Jump More Than 50% In FY 2018

Oct 17 2016

ANDA Holder Fee Will Start With Industry-Driven Database 'Clean-Up'

Oct 23 2016

Generic Industry Consolidating But Still Mysterious

Jun 07 2017

FDA Drug Pricing Policy Offers Short-Term PR Gain, More Long-Term Actual Benefit

Jun 28 2017

Additional Topics

United States FDA Generic Drugs Regulation Legislation BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window